23 November 2016 9 3K Report

Dear colleagues,

I'm going to validate few docking software tools, but I'm wondering what protocol should I choose to do this in the best way. I read some papers on validation efforts, but the routinely used methodology looks slightly strange for me.

I'd like to find out, how can the selected docking tools predict the X-ray binding pose on my set of ligands to their target proteins. I downloaded all necessary pdb files of X-ray-solved complexes, and separated proteins from ligands. And here comes the main question: should I optimize their geometry? In my opinion - yes, I should. We know that ligand conformation, in which it binds to the protein is often different from its' most energy-favourable conformation. And the same is valid for proteins - sometimes they are subjected to large conformational changes upon binding. And I think that it should be taken into account upon validation. If I just use the isolated (not optimized) conformations from the X-ray complexes, then how can I be sure that the software will be available to predict binding poses for separate ligands and proteins, not isolated from X-ray complexes? Since we don't know the X-ray structures for bound conformations of a large portion of proteins available in PDB (that can be used as drug targets), I think that we should use slightly optimized structures of proteins (and for ligands as well, basing on the same logics) instead of those isolated from crystallographic complexes upon validation of docking software.

What do you think, dear colleagues? If I am wrong, please correct me. I would be very grateful for any suggestions.

More Serhii Vakal's questions See All
Similar questions and discussions